ProfileGDS4459 / ENSG00000167139
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 34% 55% 37% 53% 37% 32% 41% 23% 32% 37% 30% 30% 43% 31% 37% 50% 25% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.8834
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.5755
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.8337
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.653
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.8937
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.7332
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.0741
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.1723
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.6132
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.9137
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.6130
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.5130
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.1443
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.8331
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.8337
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.3850
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.5525